Lista de obras - Jennifer L Sherr - Dominio Público Uruguay

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

artículo científico publicado en 2022

Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device ⬇️

artículo científico publicado el 28 de octubre de 2012

Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function

artículo científico publicado en 2012

Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.

artículo científico publicado en 2016

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus ⬇️

artículo científico publicado el 28 de agosto de 2013

Characterization of residual β cell function in long-standing type 1 diabetes.

artículo científico publicado en 2014

Clinical equipoise: an argument for expedited approval of the first small step toward an autonomous artificial pancreas ⬇️

artículo científico publicado el 1 de julio de 2012

Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults

artículo científico publicado en 2018

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes

scientific article published on 01 March 2019

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

artículo científico publicado en 2022

Diabetes types 1 and 2 in the pediatric population

scientific article published on 08 February 2012

Diabetes: Insulin pumps in children with T1DM--we told you so

artículo científico publicado en 2013

Effect of Insulin Feedback on Closed-Loop Glucose Control: A Crossover Study ⬇️

artículo científico publicado el 1 de septiembre de 2012

Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes

artículo científico publicado en 2017

Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis

artículo científico publicado en 2014

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

artículo científico publicado en 2016

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies

artículo científico publicado en 2018

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

artículo científico publicado en 2015

Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes

artículo científico publicado en 2013

Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes.

artículo científico publicado en 2017

No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year

artículo científico publicado en 2016

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

artículo científico publicado en 2018

Pramlintide but not Liraglutide suppresses meal-stimulated glucagon responses in type 1 diabetes.

artículo científico publicado en 2017

Prevention of type 1 diabetes: the time has come.

artículo científico publicado en 2008

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes ⬇️

artículo científico publicado el 11 de junio de 2013

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.

artículo científico publicado en 2016

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial ⬇️

artículo científico publicado el 21 de octubre de 2012

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

artículo científico publicado en 2017

Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.

artículo científico publicado en 2015

Lista de obras de Jennifer L Sherr

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device ⬇️

Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function

Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus ⬇️

Characterization of residual β cell function in long-standing type 1 diabetes.

Clinical equipoise: an argument for expedited approval of the first small step toward an autonomous artificial pancreas ⬇️

Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

Diabetes types 1 and 2 in the pediatric population

Diabetes: Insulin pumps in children with T1DM--we told you so

Effect of Insulin Feedback on Closed-Loop Glucose Control: A Crossover Study ⬇️

Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes

Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes

Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes.

No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

Pramlintide but not Liraglutide suppresses meal-stimulated glucagon responses in type 1 diabetes.

Prevention of type 1 diabetes: the time has come.

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes ⬇️

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial ⬇️

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.